Astal Laboratories

Astal Laboratories EBITDA per Share

The EBITDA per Share of Astal Laboratories (512600.BO) as of Oct 21, 2026 is 11.51 INR. In the previous year, EBITDA per Share was 1.13 INR — a change of 915.29% (higher).

EBITDA per Share

11.51INR

YoY

915.29%

Last updated:

EBITDA per Share of Astal Laboratories is 2025 11.51 INR. EBITDA per Share of Astal Laboratories was 2024 1.13 INR. It decreases by 915.29% higher compared to the previous year.

The Astal Laboratories EBITDA per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Share
Date
EBITDA per Share
Jan 1, 2023
-0.35 INR
Jan 1, 2024
1.13 INR
Jan 1, 2025
11.51 INR
The Astal Laboratories EBITDA per Share history
YEAREBITDA per ShareYoY
11.51INR+915.29%
1.13INR-425.38%
-0.35INR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Astal Laboratories Stock analysis

What does Astal Laboratories do? Astal Laboratories Ltd, listed on 3 January 1995, operates in the Financials sector within the Financial Services industry. The company is based in Jaipur, India, and focuses on finance and investment activities, including real estate business operations. It provides a range of financial services and investment solutions from its headquarters in Rajasthan. Astal Laboratories is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Astal Laboratories stock

EBITDA per Share of Astal Laboratories is 11.51 INR in 2025.

EBITDA per Share of Astal Laboratories changed from 1.13 INR to 11.51 INR, representing a 915.29% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Share Astal Laboratories since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Astal Laboratories

All Key Metrics — Astal Laboratories